Skip to main content

ScienceDex / Researcher record

Bali Pulendran

From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.

FY2024 NIH rank #5,032
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

$2.1M
Full award amounts, FY2024
6
Records listing this PI
#5,032
By linked amount among FY2024 PIs
2024
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2024$2,066,6106#5,032
2025$1,619,7503#9,066
2026$7,398,8236#1,481

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY2024 · selected6 records
  2. FY20253 records
  3. FY20266 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Bali Pulendran. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 6189157Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.

FY2026 award categories

  • Pathology
  • Internal Medicine

FY2024 award records by amount

NIH award records listing Bali Pulendran as a PI. Multi-PI records show the full award amount for context.

  • 5U01AI165527-03U01Contact PI
    Systems biological assessment of vaccination-induced protective immunity in African children
    Stanford University · Pathology (NIH department code)
    $532K
    award amount
  • 5U01HL163124-03U01Co-investigator
    Vaccination responses in lung transplant recipients
    Stanford University · Internal Medicine (NIH department code)
    $412.1K
    award amount
  • 5R01AI048638-24R01Contact PI
    Metabolic imprinting of dendritic cell fate and function in tissues
    Stanford University · Pathology (NIH department code)
    $367.4K
    award amount
  • 5U19AI167903-03U19Contact PI
    Systems biological assessment of innate and adaptive immunity to vaccination
    $334.5K
    award amount
  • 5U19AI159840-04U19Contact PI
    A vaccine design to induce protective B and T cell immunity against hepatitis C virus
    $302.4K
    award amount
  • 3R01AI048638-24S1R01Contact PI
    Metabolic imprinting of dendritic cell fate and function in tissues
    Stanford University · Pathology (NIH department code)
    $118.3K
    award amount

Award organization

Organizations that administered FY2024 awards listing Bali Pulendran as a PI.

FY2024 award administered by Stanford University (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Stanford University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #5032
  6. 2025
    R01 Grant Holder
  7. 2025
    Program/Center Grant Leader
  8. 2026
    $5M Cumulative Funding
  9. 2026
    $10M Cumulative Funding
  10. 2026
    Entered Top 25% Nationally
    Ranked #1481
  11. 2026
    Entered Top 10% Nationally
    Ranked #1481